Citations (228)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (15)
Adam Zalewski & Jacek C. Szepietowski. (2023) Topical and systemic JAK inhibitors in hand eczema – a narrative review. Expert Review of Clinical Immunology 19:4, pages 365-373.
Read now
Read now
Yufei Fu, Fanfan Zhu, Zhongjun Ma, Bin Lv, Xi Wang, Chunyan Dai, Xiaoqiong Ma, Pei Liu, Hang Lv, Xin Chen, Zhe Chen & Li Shen. (2021) Physalis alkekengi var. franchetii Extracts Exert Antitumor Effects on Non-Small Cell Lung Cancer and Multiple Myeloma by Inhibiting STAT3 Signaling. OncoTargets and Therapy 14, pages 301-314.
Read now
Read now
Mahnaz Mohammadi Kian, Mahdieh Salemi, Mohammad Bahadoran, Atousa Haghi, Nasrin Dashti, Saeed Mohammadi, Shahrbano Rostami, Bahram Chahardouli, Davood Babakhani & Mohsen Nikbakht. (2020) Curcumin Combined with Thalidomide Reduces Expression of STAT3 and Bcl-xL, Leading to Apoptosis in Acute Myeloid Leukemia Cell Lines. Drug Design, Development and Therapy 14, pages 185-194.
Read now
Read now
Giulio Poli, Arianna Gelain, Federica Porta, Akira Asai, Adriano Martinelli & Tiziano Tuccinardi. (2016) Identification of a new STAT3 dimerization inhibitor through a pharmacophore-based virtual screening approach. Journal of Enzyme Inhibition and Medicinal Chemistry 31:6, pages 1011-1017.
Read now
Read now
Yan Liang, Hai-Feng Pan & Dong-Qing Ye. (2014) Therapeutic potential of STAT4 in autoimmunity. Expert Opinion on Therapeutic Targets 18:8, pages 945-960.
Read now
Read now
Antonio Lavecchia, Carmen Di Giovanni & Carmen Cerchia. (2014) Novel inhibitors of signal transducer and activator of transcription 3 signaling pathway: an update on the recent patent literature. Expert Opinion on Therapeutic Patents 24:4, pages 383-400.
Read now
Read now
Karolina Swiatek-Machado, Jakub Mieczkowski, Aleksandra Ellert-Miklaszewska, Piotr Swierk, Izabela Fokt, Slawomir Szymanski, Stanislaw Skora, Wiesław Szeja, Grzegorz Grynkiewicz, Bogdan Lesyng, Waldemar Priebe & Bozena Kaminska. (2012) Novel small molecular inhibitors disrupt the JAK/STAT3 and FAK signaling pathways and exhibit a potent antitumor activity in glioma cells. Cancer Biology & Therapy 13:8, pages 657-670.
Read now
Read now
Raj Kishore & Suresh K. Verma. (2012) Roles of STATs signaling in cardiovascular diseases. JAK-STAT 1:2, pages 118-124.
Read now
Read now
Lei Li, Jin Zeng, Ye Gao & Dalin He. (2010) Targeting silibinin in the antiproliferative pathway. Expert Opinion on Investigational Drugs 19:2, pages 243-255.
Read now
Read now
Mingzhu Zhu, Lei Gao, Xia Li, Zhicheng Liu, Chun Xu, Yuqing Yan, Erin Walker, Wei Jiang, Bin Su, Xiujie Chen & Hui Lin. (2009) The analysis of the drug–targets based on the topological properties in the human protein–protein interaction network. Journal of Drug Targeting 17:7, pages 524-532.
Read now
Read now
Peibin Yue & James Turkson. (2009) Targeting STAT3 in cancer: how successful are we?. Expert Opinion on Investigational Drugs 18:1, pages 45-56.
Read now
Read now
Madeleine Duvic & Jenny Vu. (2007) Update on the treatment of cutaneous T-cell lymphoma (CTCL): Focus on vorinostat. Biologics: Targets and Therapy 1:4, pages 377-392.
Read now
Read now
Thomas Meyer & Uwe Vinkemeier. (2007) STAT nuclear translocation: potential for pharmacological intervention. Expert Opinion on Therapeutic Targets 11:10, pages 1355-1365.
Read now
Read now
Madeleine Duvic & Jenny Vu. (2007) Vorinostat: a new oral histone deacetylase inhibitor approved for cutaneous T-cell lymphoma. Expert Opinion on Investigational Drugs 16:7, pages 1111-1120.
Read now
Read now
Corina Borghouts, Christian Kunz & Bernd Groner. (2005) Peptide aptamers: recent developments for cancer therapy. Expert Opinion on Biological Therapy 5:6, pages 783-797.
Read now
Read now
Articles from other publishers (213)
Sinem Örnek, Selver Ozekinci, Tugba Ipin & Emek Kocaturk. (2023)
TOX
,
TWIST1
,
STAT4
, and
SATB1
protein expressions in early‐stage mycosis fungoides
. Journal of Cutaneous Pathology.
Crossref
Crossref
Mehrdad Hashemi, Sahar Abbaszadeh, Mohsen Rashidi, Nafisesadat Amini, Kasra Talebi Anaraki, Motahhar Motahhary, Ensi Khalilipouya, Abdorrahman Harif Nashtifani, Sasan Shafiei, Marzieh Ramezani Farani, Noushin Nabavi, Shokooh Salimimoghadam, Amir Reza Aref, Rasoul Raesi, Afshin Taheriazam, Maliheh Entezari & Wenliang Zha. (2023) STAT3 as a newly emerging target in colorectal cancer therapy: Tumorigenesis, therapy response, and pharmacological/nanoplatform strategies. Environmental Research 233, pages 116458.
Crossref
Crossref
Lingfei Li, Mingyang Li & Qingge Jia. (2023) Myeloid-derived suppressor cells: Key immunosuppressive regulators and therapeutic targets in cancer. Pathology - Research and Practice 248, pages 154711.
Crossref
Crossref
Rawiah A. Alsiary, Talat Abdullah Albukhari & Waheed A. Filimban. 2023. Molecular Targets and Cancer Therapeutics (Part 1). Molecular Targets and Cancer Therapeutics (Part 1)
273
319
.
Yuchen Tao, Wenhang Li, Jianying Yang, Tingting Xue, Yanlu Wang, Xiaojie Dong, Hao Xu, Jianye Ren & Jiahui Lu. (2023) Exploring underlying mechanism of artesunate in treatment of acute myeloid leukemia using network pharmacology and molecular docking. Clinical and Translational Oncology 25:8, pages 2427-2437.
Crossref
Crossref
Yussef Esparza Guerrero, Maria Luisa Vazquez Villegas, Cesar Arturo Nava Valdivia, Juan Manuel Ponce Guarneros, Edsaul Emilio Perez Guerrero, Eli Efrain Gomez Ramirez, Melissa Ramirez Villafaña, Betsabe Contreras Haro, Alejandra Martinez Hernandez, Ernesto German Cardona Muñoz, Ismael Nuño Arana, Sergio Gabriel Gallardo Moya, Alfredo Celis, Laura Gonzalez Lopez, Jorge Ivan Gamez Nava & Ana Miriam Saldaña Cruz. (2023) Association of the STAT4 Gene rs7574865 Polymorphism with IFN-γ Levels in Patients with Systemic Lupus Erythematosus. Genes 14:3, pages 537.
Crossref
Crossref
Marta Rusek, Joanna Smith, Kamel El-Khatib, Kennedy Aikins, Stanisław J. Czuczwar & Ryszard Pluta. (2023) The Role of the JAK/STAT Signaling Pathway in the Pathogenesis of Alzheimer’s Disease: New Potential Treatment Target. International Journal of Molecular Sciences 24:1, pages 864.
Crossref
Crossref
Chandrabose Selvaraj, Karthik Raja Ramalingam, Devadasan Velmurugan & Sanjeev Kumar Singh. 2023. Regulation of Downstream Targets. Regulation of Downstream Targets
1
20
.
Yinsong Zhu, Peibin Yue, Cody F. Dickinson, Justin K. Yang, Kyrstin Datanagan, Ning Zhai, Yi Zhang, Gabriella Miklossy, Francisco Lopez-Tapia, Marcus A. Tius & James Turkson. (2022) Natural product preferentially targets redox and metabolic adaptations and aberrantly active STAT3 to inhibit breast tumor growth in vivo. Cell Death & Disease 13:12.
Crossref
Crossref
Kagiso Laka, Ladislaus Mdee & Zukile Mbita. (2022) Drimia calcarata Bulb Extracts Deactivate the PI3K Signalling Pathway in Cervical HPV-18 Positive HeLa Cells. Clinical Complementary Medicine and Pharmacology 2:4, pages 100054.
Crossref
Crossref
Hardeep Singh Tuli, Katrin Sak, Ashif Iqubal, Vivek Kumar Garg, Mehmet Varol, Uttam Sharma, Abhishek Chauhan, Mukerrem Betul Yerer, Kuldeep Dhama, Manju Jain & Aklank Jain. (2022) STAT signaling as a target for intervention: from cancer inflammation and angiogenesis to non-coding RNAs modulation. Molecular Biology Reports 49:9, pages 8987-8999.
Crossref
Crossref
Elnaz Faghfuri, Mohsen Sagha & Amir Hossein Faghfouri. (2021) The Cytotoxicity Effect of Curcumin Loaded Folic Acid Conjugated-Nanoparticles on Breast Cancer Cells and Its Association with Inhibition of STAT3 Phosphorylation. Journal of Cluster Science 33:5, pages 2037-2044.
Crossref
Crossref
Shishay Girmay, Hafiz Ishfaq Ahmad & Quratul Ain Zahra. (2022) A Simulation Analysis and Screening of Deleterious Nonsynonymous Single Nucleotide Polymorphisms (nsSNPs) in Sheep LEP Gene. BioMed Research International 2022, pages 1-9.
Crossref
Crossref
Erum Zafar, Muhammad Faisal Maqbool, Asia Iqbal, Amara Maryam, Hafiz Abdullah Shakir, Muhammad Irfan, Muhammad Khan, Yongming Li & Tonghui Ma. (2021) A comprehensive review on anticancer mechanism of bazedoxifene. Biotechnology and Applied Biochemistry 69:2, pages 767-782.
Crossref
Crossref
Xu Feng, Ning Guan, Enshi Xu, Ye Miao & Chenguang Li. (2021) Transcription Factors Leading to High Expression of Neuropeptide L1CAM in Brain Metastases from Lung Adenocarcinoma and Clinical Prognostic Analysis. Disease Markers 2021, pages 1-15.
Crossref
Crossref
Mariia Radaeva, Anh-Tien Ton, Michael Hsing, Fuqiang Ban & Artem Cherkasov. (2021) Drugging the ‘undruggable’. Therapeutic targeting of protein–DNA interactions with the use of computer-aided drug discovery methods. Drug Discovery Today 26:11, pages 2660-2679.
Crossref
Crossref
Fan Luo, Fei-Teng Lu, Miao-Zhen Qiu, Ting Zhou, Wen-Juan Ma, Min Luo, Kang-Mei Zeng, Qiu-Yun Luo, Wen-Tao Pan, Lin Zhang, Zeng-Fei Xia, Zhong-Han Zhang, Jia-Xin Cao, Hong-Yun Zhao, Li Zhang & Da-Jun Yang. (2021) Gemcitabine and APG-1252, a novel small molecule inhibitor of BCL-2/BCL-XL, display a synergistic antitumor effect in nasopharyngeal carcinoma through the JAK-2/STAT3/MCL-1 signaling pathway. Cell Death & Disease 12:8.
Crossref
Crossref
Anna Caruso, Alexia Barbarossa, Alessia Carocci, Giovanni Salzano, Maria Stefania Sinicropi & Carmela Saturnino. (2021) Carbazole Derivatives as STAT Inhibitors: An Overview. Applied Sciences 11:13, pages 6192.
Crossref
Crossref
Mohammad rafi Khezri, Hassan Malekinejad, Naime Majidi-Zolbanin & Morteza Ghasemnejad-Berenji. (2021) Anticancer potential of metformin: focusing on gastrointestinal cancers. Cancer Chemotherapy and Pharmacology 87:5, pages 587-598.
Crossref
Crossref
Dingding Gao, Nan Jin, Yixian Fu, Yueyue Zhu, Yujie Wang, Ting Wang, Yuehong Chen, Mingming Zhang, Qiang Xiao, Min Huang & Yingxia Li. (2021) Rational drug design of benzothiazole-based derivatives as potent signal transducer and activator of transcription 3 (STAT3) signaling pathway inhibitors. European Journal of Medicinal Chemistry 216, pages 113333.
Crossref
Crossref
Mehmet Berköz, Ferbal Özkan-Yılmaz, Arzu Özlüer-Hunt, Mirosław Krośniak, Ömer Türkmen, Duygu Korkmaz & Sıddık Keskin. (2021) Artesunate inhibits melanoma progression in vitro via suppressing STAT3 signaling pathway. Pharmacological Reports 73:2, pages 650-663.
Crossref
Crossref
Jamie V. Shiah, Jennifer R. Grandis & Daniel E. Johnson. (2021) Targeting STAT3 with Proteolysis Targeting Chimeras and Next-Generation Antisense Oligonucleotides. Molecular Cancer Therapeutics 20:2, pages 219-228.
Crossref
Crossref
Salah A. Sheweita, Rania G. Ammar, Sally A. Sabra & Ahmed S. Sultan. (2021) Letrozole and zoledronic acid changed signalling pathways involved in the apoptosis of breast cancer cells. Journal of Taibah University Medical Sciences 16:1, pages 112-120.
Crossref
Crossref
Christine Brotherton-Pleiss, Peibin Yue, Yinsong Zhu, Kayo Nakamura, Weiliang Chen, Wenzhen Fu, Casie Kubota, Jasmine Chen, Felix Alonso-Valenteen, Simoun Mikhael, Lali Medina-Kauwe, Marcus A. Tius, Francisco Lopez-Tapia & James Turkson. (2020) Discovery of Novel Azetidine Amides as Potent Small-Molecule STAT3 Inhibitors. Journal of Medicinal Chemistry 64:1, pages 695-710.
Crossref
Crossref
Nigus D. Ambaye & Hua E. Yu. (2020) Novel anti‐cancer candidates from a combinatorial peptide library. Chemical Biology & Drug Design 97:1, pages 87-96.
Crossref
Crossref
Madeleine R. Berendsen, Wendy B. C. Stevens, Michiel van den Brand, J. Han van Krieken & Blanca Scheijen. (2020) Molecular Genetics of Relapsed Diffuse Large B-Cell Lymphoma: Insight into Mechanisms of Therapy Resistance. Cancers 12:12, pages 3553.
Crossref
Crossref
Xinyu Ji, Lijuan Lin, Sipeng Shen, Xuesi Dong, Chao Chen, Yi Li, Ying Zhu, Hui Huang, Jiajin Chen, Xin Chen, Liangmin Wei, Jieyu He, Weiwei Duan, Li Su, Yue Jiang, Juanjuan Fan, Jinxing Guan, Dongfang You, Andrea Shafer, Maria Moksnes Bjaanæs, Anna Karlsson, Maria Planck, Johan Staaf, Åslaug Helland, Manel Esteller, Yongyue Wei, Ruyang Zhang, Feng Chen & David C. Christiani. (2020)
Epigenetic–smoking interaction reveals histologically heterogeneous effects of
TRIM27
DNA methylation on overall survival among early‐stage NSCLC patients
. Molecular Oncology 14:11, pages 2759-2774.
Crossref
Crossref
Meaghan H. Hancock, Jennifer Mitchell, Felicia D. Goodrum & Jay A. Nelson. (2020)
Human Cytomegalovirus miR-US5-2 Downregulation of GAB1 Regulates Cellular Proliferation and
UL138
Expression through Modulation of Epidermal Growth Factor Receptor Signaling Pathways
. mSphere 5:4.
Crossref
Crossref
Xin Qi, Meng Li, Xiao-min Zhang, Xiu-fen Dai, Jian Cui, De-hai Li, Qian-qun Gu, Zhi-hua Lv & Jing Li. (2020) Trichothecin Inhibits Cancer-Related Features in Colorectal Cancer Development by Targeting STAT3. Molecules 25:10, pages 2306.
Crossref
Crossref
Samarwadee Plianwong, Bindu Thapa, Remant Bahadur KC, Cezary Kucharski, Theerasak Rojanarata & Hasan Uludağ. (2020) Enabling Combinatorial siRNA Delivery against Apoptosis-Related Proteins with Linoleic Acid and α-Linoleic Acid Substituted Low Molecular Weight Polyethylenimines. Pharmaceutical Research 37:3.
Crossref
Crossref
Sundas Arshad, Muhammad Naveed, Mahad Ullia, Khadija Javed, Ayesha Butt, Masooma Khawar & Fazeeha Amjad. (2020) Targeting STAT-3 signaling pathway in cancer for development of novel drugs: Advancements and challenges. Genetics and Molecular Biology 43:1.
Crossref
Crossref
Karolina Swiatek-Machado & Bozena Kaminska. 2020. Glioma Signaling. Glioma Signaling
203
222
.
Violetta Krajka-Kuźniak, Barbara Bednarczyk-Cwynar, Maria Narożna, Hanna Szaefer & Wanda Baer-Dubowska. (2019) Morpholide derivative of the novel oleanolic oxime and succinic acid conjugate diminish the expression and activity of NF-κB and STATs in human hepatocellular carcinoma cells. Chemico-Biological Interactions 311, pages 108786.
Crossref
Crossref
Bruna Gazzi de Lima-Seolin, Ashley Nemec-Bakk, Heidi Forsyth, Stefanie Kirk, Alex Sander da Rosa Araujo, Paulo Cavalheiro Schenkel, Adriane Belló-Klein & Neelam Khaper. (2019) Bucindolol Modulates Cardiac Remodeling by Attenuating Oxidative Stress in H9c2 Cardiac Cells Exposed to Norepinephrine. Oxidative Medicine and Cellular Longevity 2019, pages 1-11.
Crossref
Crossref
Stella Sravanthi V.Bhagath Kumar Palaka, Gnana vel, Rengarajan Venkatesan, Dinakara Rao Ampasala & Latha Periyasamy. (2019) Identification of novel inhibitors of signal transducer and activator of transcription 3 over signal transducer and activator of transcription 1 for the treatment of breast cancer by in-silico and in-vitro approach. Process Biochemistry 82, pages 153-166.
Crossref
Crossref
Tatsuya Koseki, Naoya Suehiro, Yoshiaki Masuda, Nao Miyoshi, Daisuke Muraoka, Naohisa Ogo & Akira Asai. (2019) Discovery of a New STAT3 Inhibitor Acting on the Linker Domain. Biological and Pharmaceutical Bulletin 42:5, pages 792-800.
Crossref
Crossref
Eun Ji Lee, Su-Jung Kim, Young-Il Hahn, Hyo-Jin Yoon, Bitnara Han, Kyeojin Kim, Seungbeom Lee, Kwang Pyo Kim, Young Ger Suh, Hye-Kyung Na & Young-Joon Surh. (2019) 15-Keto prostaglandin E2 suppresses STAT3 signaling and inhibits breast cancer cell growth and progression. Redox Biology 23, pages 101175.
Crossref
Crossref
Agnieszka Krzyzanowska, Nicholas Don‐Doncow, Felicia Elena Marginean, Alexander Gaber, R. William Watson, Rebecka Hellsten & Anders Bjartell. (2019)
Expression of tSTAT3, pSTAT3
727
, and pSTAT3
705
in the epithelial cells of hormone‐naïve prostate cancer
. The Prostate 79:7, pages 784-797.
Crossref
Crossref
Shengling Fu, Xiang Chen, Hui-Wen Lo & Jiayuh Lin. (2019) Combined bazedoxifene and paclitaxel treatments inhibit cell viability, cell migration, colony formation, and tumor growth and induce apoptosis in breast cancer. Cancer Letters 448, pages 11-19.
Crossref
Crossref
Eleanor C. FiedlerMichael T. Hemann. (2019) Aiding and Abetting: How the Tumor Microenvironment Protects Cancer from Chemotherapy. Annual Review of Cancer Biology 3:1, pages 409-428.
Crossref
Crossref
Jia‐Peng Li, Yuan Xiang, Li‐Juan Fan, Ao Yao, Hui Li & Xing‐Hua Liao. (2018) Long noncoding RNA H19 competitively binds miR‐93‐5p to regulate STAT3 expression in breast cancer. Journal of Cellular Biochemistry 120:3, pages 3137-3148.
Crossref
Crossref
Chin-Yap Loh, Aditya Arya, Ahmed Fadhil Naema, Won Fen Wong, Gautam Sethi & Chung Yeng Looi. (2019) Signal Transducer and Activator of Transcription (STATs) Proteins in Cancer and Inflammation: Functions and Therapeutic Implication. Frontiers in Oncology 9.
Crossref
Crossref
Yang Yang & Zhi Shi. 2019. Protein Kinase Inhibitors as Sensitizing Agents for Chemotherapy. Protein Kinase Inhibitors as Sensitizing Agents for Chemotherapy
53
65
.
Shuntao Wang, Lili Yu, Wei Shi, Xueqin Li & Lixiu Yu. (2018) Prognostic roles of signal transducers and activators of transcription family in human breast cancer. Bioscience Reports 38:6.
Crossref
Crossref
Dan Li, Gangcheng Wang, Guoguo Jin, Ke Yao, Zhenjiang Zhao, Liangyu Bie, Yongjun Guo, Ning Li, Wenying Deng, Xiaobin Chen, Beibei Chen, Yuanyuan Liu, Suxia Luo & Zhiping Guo. (2018) Resveratrol suppresses colon cancer growth by targeting the AKT/STAT3 signaling pathway. International Journal of Molecular Medicine.
Crossref
Crossref
Ajaz A. Bhat, Heng Lu, Mohammed Soutto, Anthony Capobianco, Priyamvada Rai, Alexander Zaika & Wael El-Rifai. (2018) Exposure of Barrett’s and esophageal adenocarcinoma cells to bile acids activates EGFR–STAT3 signaling axis via induction of APE1. Oncogene 37:46, pages 6011-6024.
Crossref
Crossref
Pingyu Zhang & Huaiyi Huang. (2018) Future potential of osmium complexes as anticancer drug candidates, photosensitizers and organelle-targeted probes. Dalton Transactions 47:42, pages 14841-14854.
Crossref
Crossref
In‐Hyoung Yang, Won Jung, Lee‐Han Kim, Ji‐Ae Shin, Nam‐Pyo Cho, Seong Doo Hong, Kyoung‐Ok Hong & Sung‐Dae Cho. (2018) Nitidine chloride represses Mcl‐1 protein via lysosomal degradation in oral squamous cell carcinoma. Journal of Oral Pathology & Medicine 47:9, pages 823-829.
Crossref
Crossref
Ilenia Segatto, Gustavo Baldassarre & Barbara Belletti. (2018) STAT3 in Breast Cancer Onset and Progression: A Matter of Time and Context. International Journal of Molecular Sciences 19:9, pages 2818.
Crossref
Crossref
Paul J. M. Jackson, Shirin Jamshidi & Doaa B. Farag. 2018. Small-molecule Transcription Factor Inhibitors in Oncology. Small-molecule Transcription Factor Inhibitors in Oncology
42
54
.
Kaja Rupar, Sausan A. Moharram, Julhash U. Kazi & Lars Rönnstrand. (2018) SRC-like adaptor protein 2 (SLAP2) is a negative regulator of KIT-D816V-mediated oncogenic transformation. Scientific Reports 8:1.
Crossref
Crossref
Francisco Lopez-Tapia, Christine Brotherton-Pleiss, Peibin Yue, Heide Murakami, Ana Carolina Costa Araujo, Bruna Reis dos Santos, Erin Ichinotsubo, Anna Rabkin, Raj Shah, Megan Lantz, Suzie Chen, Marcus A. Tius & James Turkson. (2018) Linker Variation and Structure–Activity Relationship Analyses of Carboxylic Acid-based Small Molecule STAT3 Inhibitors. ACS Medicinal Chemistry Letters 9:3, pages 250-255.
Crossref
Crossref
Md. Abdullah Al Noman, Tasnova Hossain, Monira Ahsan, Shirin JamshidiChoudhury Mahmood Hasan & Khondaker Miraz Rahman. (2018)
Crispenes F and G,
cis
-Clerodane Furanoditerpenoids from
Tinospora crispa
, Inhibit STAT3 Dimerization
. Journal of Natural Products 81:2, pages 236-242.
Crossref
Crossref
Jingtong Pan, Wenyi Ruan, Mengyao Qin, Yueming Long, Tao Wan, Kaiyue Yu, Yuanhao Zhai, Chuanbin Wu & Yuehong Xu. (2018) Intradermal delivery of STAT3 siRNA to treat melanoma via dissolving microneedles. Scientific Reports 8:1.
Crossref
Crossref
Kaja Rupar, Julhash U. Kazi & Lars Rönnstrand. 2018. Encyclopedia of Signaling Molecules. Encyclopedia of Signaling Molecules
2772
2776
.
Sankar Jagadeeshan, Diana David, S. Jisha, S. Manjula & S. Asha Nair. (2017) Solanum nigrum Unripe fruit fraction attenuates Adriamycin resistance by down-regulating multi-drug resistance protein (Mdr)-1 through Jak-STAT pathway. BMC Complementary and Alternative Medicine 17:1.
Crossref
Crossref
Sehamuddin Galadari, Anees Rahman, Siraj Pallichankandy & Faisal Thayyullathil. (2017) Molecular targets and anticancer potential of sanguinarine—a benzophenanthridine alkaloid. Phytomedicine 34, pages 143-153.
Crossref
Crossref
Shegan Gao, Shuoguo Li, Xiaoxian Duan, Zhen Gu, Zhikun Ma, Xiang Yuan, Xiaoshan Feng & Huizhi Wang. (2017) Inhibition of glycogen synthase kinase 3 beta (GSK3β) suppresses the progression of esophageal squamous cell carcinoma by modifying STAT3 activity. Molecular Carcinogenesis 56:10, pages 2301-2316.
Crossref
Crossref
Shuai Li, Xiaochen Guo, Teng Zhang, Nan Wang, Junyan Li, Pengfei Xu, Shengqi Zhang, Guiping Ren & Deshan Li. (2017) Fibroblast growth factor 21 ameliorates high glucose-induced fibrogenesis in mesangial cells through inhibiting STAT5 signaling pathway. Biomedicine & Pharmacotherapy 93, pages 695-704.
Crossref
Crossref
Shan-Shan Liu, Ning Liu, Meng-Yao Liu, Lei Sun, Wu-Yan Xia, Hong-Min Lu, Yu-Jie Fu, Guo-Liang Yang, Juan-Jie Bo, Xiao-Xing Liu, Haizhong Feng, Hailong Wu, Lin-Feng Li & Jian-Xin Gao. (2017)
An unusual intragenic promoter of
PIWIL2
contributes to aberrant activation of oncogenic
PL2L60
. Oncotarget 8:28, pages 46104-46120.
Crossref
Crossref
Nicole M. Jackson & Brian P. Ceresa. (2017) EGFR-mediated apoptosis via STAT3. Experimental Cell Research 356:1, pages 93-103.
Crossref
Crossref
Koji OsukaYasuo WatanabeNobuteru UsudaMasahiro AoyamaKenichiro IwamiMikinobu TakeuchiTakeya WatabeMasakazu Takayasu. (2017) Inhibitory Mechanism of the Outer Membrane Growth of Chronic Subdural Hematomas. Journal of Neurotrauma 34:11, pages 1996-2000.
Crossref
Crossref
Tyvette S. Hilliard, Gabriella Miklossy, Christopher Chock, Peibin Yue, Philip Williams & James Turkson. (2017)
15α-methoxypuupehenol Induces Antitumor Effects
In Vitro
and
In Vivo
against Human Glioblastoma and Breast Cancer Models
. Molecular Cancer Therapeutics 16:4, pages 601-613.
Crossref
Crossref
Quyen Thu Bui, Ji Hye Im, Sung Baek Jeong, Young-Mi Kim, Sung Chul Lim, Bumseok Kim & Keon Wook Kang. (2017) Essential role of Notch4/STAT3 signaling in epithelial–mesenchymal transition of tamoxifen-resistant human breast cancer. Cancer Letters 390, pages 115-125.
Crossref
Crossref
Bo Li & Chen Huang. (2017) Regulation of EMT by STAT3 in gastrointestinal cancer (Review). International Journal of Oncology 50:3, pages 753-767.
Crossref
Crossref
Roberta Cirincione, Federica Maria Di Maggio, Giusi Irma Forte, Luigi Minafra, Valentina Bravatà, Laura Castiglia, Vincenzo Cavalieri, Giovanni Borasi, Giorgio Russo, Domenico Lio, Cristina Messa, Maria Carla Gilardi & Francesco Paolo Cammarata. (2017) High-Intensity Focused Ultrasound– and Radiation Therapy–Induced Immuno-Modulation: Comparison and Potential Opportunities. Ultrasound in Medicine & Biology 43:2, pages 398-411.
Crossref
Crossref
Ildefonso Alves da Silva Junior, Simone Cardozo Stone, Renata Marques Rossetti, Sonia Jancar & Ana Paula Lepique. (2017) Modulation of Tumor-Associated Macrophages (TAM) Phenotype by Platelet-Activating Factor (PAF) Receptor. Journal of Immunology Research 2017, pages 1-10.
Crossref
Crossref
James Turkson. 2017. The Molecular Basis of Human Cancer. The Molecular Basis of Human Cancer
695
707
.
Akira Asai & Kazuyuki Takakuma. 2017. SH2 Domains. SH2 Domains
163
172
.
Chenbo Ding, Longmei Li, Taoyu Yang, Xiaobo Fan & Guoqiu Wu. (2016) Combined application of anti-VEGF and anti-EGFR attenuates the growth and angiogenesis of colorectal cancer mainly through suppressing AKT and ERK signaling in mice model. BMC Cancer 16:1.
Crossref
Crossref
Meihua Liang, Fei Zhan, Juan Zhao, Qi Li, Jiazi Wuyang, Guannan Mu, Dianjun Li, Yanqiao Zhang & Xiaoyi Huang. (2016) CPA-7 influences immune profile and elicits anti-prostate cancer effects by inhibiting activated STAT3. BMC Cancer 16:1.
Crossref
Crossref
Li-Juan Liu, Wanhe Wang, Tian-Shu Kang, Jia-Xin Liang, Chenfu Liu, Daniel W. J. Kwong, Vincent Kam Wai Wong, Dik-Lung Ma & Chung-Hang Leung. (2016) Antagonizing STAT5B dimerization with an osmium complex. Scientific Reports 6:1.
Crossref
Crossref
Bin Xiao, Dongjing Lin, Xuan Zhang, Meilan Zhang & Xuewu Zhang. (2016) TTF1, in the Form of Nanoparticles, Inhibits Angiogenesis, Cell Migration and Cell Invasion In Vitro and In Vivo in Human Hepatoma through STAT3 Regulation. Molecules 21:11, pages 1507.
Crossref
Crossref
Shu Liu, Chunmei Hu, Yingxue Wang, Guang Shi, Yarong Li & Huang Wu. (2016) miR-124 inhibits proliferation and invasion of human retinoblastoma cells by targeting STAT3. Oncology Reports 36:4, pages 2398-2404.
Crossref
Crossref
Yan-hong Liu, Jia-lu Jin, Yu-zhe Wang, Ying Tan, Ying-ying Zhou, Ting Peng, Feng Li, Wan-dong Liang, Pascal Chartrand, Yu-yang Jiang & Zhi-fa Shen. (2016) Protrusion-localized STAT3 mRNA promotes metastasis of highly metastatic hepatocellular carcinoma cells in vitro. Acta Pharmacologica Sinica 37:6, pages 805-813.
Crossref
Crossref
Dingding Gao, Qiang Xiao, Mingming Zhang & Yingxia Li. (2016) Design, synthesis and biological evaluation of benzyloxyphenyl-methylaminophenol derivatives as STAT3 signaling pathway inhibitors. Bioorganic & Medicinal Chemistry 24:11, pages 2549-2558.
Crossref
Crossref
Roxane Khoogar, Byung-Chang Kim, Jay Morris & Michael J. Wargovich. (2016) Chemoprevention in gastrointestinal physiology and disease. Targeting the progression of cancer with natural products: a focus on gastrointestinal cancer. American Journal of Physiology-Gastrointestinal and Liver Physiology 310:9, pages G629-G644.
Crossref
Crossref
TAO PENG, LIXIANG ZHOU, LING ZUO & YONGXIN LUAN. (2016) miR-506 functions as a tumor suppressor in glioma by targeting STAT3. Oncology Reports 35:2, pages 1057-1064.
Crossref
Crossref
Peibin Yue, Francisco Lopez-Tapia, David Paladino, Yifei Li, Chih-Hong Chen, Andrew T. Namanja, Tyvette Hilliard, Yuan Chen, Marcus A. Tius & James Turkson. (2016)
Hydroxamic Acid and Benzoic Acid–Based STAT3 Inhibitors Suppress Human Glioma and Breast Cancer Phenotypes
In Vitro
and
In Vivo
. Cancer Research 76:3, pages 652-663.
Crossref
Crossref
Elango Bhakkiyalakshmi, Natarajan Suganya, Dornadula Sireesh, Kannan Krishnamurthi, Sivanesan Saravana Devi, Palanisamy Rajaguru & Kunka Mohanram Ramkumar. (2016) Carvacrol induces mitochondria-mediated apoptosis in HL-60 promyelocytic and Jurkat T lymphoma cells. European Journal of Pharmacology 772, pages 92-98.
Crossref
Crossref
Shih‐Chiang Huang, Chien‐Feng Li, Yu‐Chien Kao, I‐Chieh Chuang, Hui‐Chun Tai, Jen‐Wei Tsai, Shih‐Chen Yu, Hsuan‐Ying Huang, Jui Lan, Shao‐Lun Yen, Po‐Chun Lin & Tse‐Ching Chen. (2015)
The clinicopathological significance of
NAB
2‐
STAT
6
gene fusions in 52 cases of intrathoracic solitary fibrous tumors
. Cancer Medicine 5:2, pages 159-168.
Crossref
Crossref
Chao-Lan Yu, Richard Jove & James Turkson. 2016. STAT Inhibitors in Cancer. STAT Inhibitors in Cancer
69
94
.
Kaja Rupar, Julhash U. Kazi & Lars Rönnstrand. 2016. Encyclopedia of Signaling Molecules. Encyclopedia of Signaling Molecules
1
5
.
MINGHE LI, ZHIHONG LI, JIA LI, LIOU JIN, CHENGXUE JIN, CHENGMIN HAN, XIN JI & FEI SUN. (2015) Enhanced antitumor effect of cisplatin in human oral squamous cell carcinoma cells by tumor suppressor GRIM-19. Molecular Medicine Reports 12:6, pages 8185-8192.
Crossref
Crossref
Ramzi M. Mohammad, Irfana Muqbil, Leroy Lowe, Clement Yedjou, Hsue-Yin Hsu, Liang-Tzung Lin, Markus David Siegelin, Carmela Fimognari, Nagi B. Kumar, Q. Ping Dou, Huanjie Yang, Abbas K. Samadi, Gian Luigi Russo, Carmela Spagnuolo, Swapan K. Ray, Mrinmay Chakrabarti, James D. Morre, Helen M. Coley, Kanya Honoki, Hiromasa Fujii, Alexandros G. Georgakilas, Amedeo Amedei, Elena Niccolai, Amr Amin, S. Salman Ashraf, William G. Helferich, Xujuan Yang, Chandra S. Boosani, Gunjan Guha, Dipita Bhakta, Maria Rosa Ciriolo, Katia Aquilano, Sophie Chen, Sulma I. Mohammed, W. Nicol Keith, Alan Bilsland, Dorota Halicka, Somaira Nowsheen & Asfar S. Azmi. (2015) Broad targeting of resistance to apoptosis in cancer. Seminars in Cancer Biology 35, pages S78-S103.
Crossref
Crossref
Hyerim Song, Jae In Jung, Han Jin Cho, Song Her, Seung-Hae Kwon, Rina Yu, Young-Hee Kang, Ki Won Lee & Jung Han Yoon Park. (2015) Inhibition of tumor progression by oral piceatannol in mouse 4T1 mammary cancer is associated with decreased angiogenesis and macrophage infiltration. The Journal of Nutritional Biochemistry 26:11, pages 1368-1378.
Crossref
Crossref
Gabriella Miklossy, Ui Joung Youn, Peibin Yue, Mingming Zhang, Chih-Hong Chen, Tyvette S. Hilliard, David Paladino, Yifei Li, Justin Choi, Jann N. Sarkaria, Joel K. Kawakami, Supakit Wongwiwatthananukit, Yuan Chen, Dianqing Sun, Leng Chee Chang & James Turkson. (2015) Hirsutinolide Series Inhibit Stat3 Activity, Alter GCN1, MAP1B, Hsp105, G6PD, Vimentin, TrxR1, and Importin α-2 Expression, and Induce Antitumor Effects against Human Glioma. Journal of Medicinal Chemistry 58:19, pages 7734-7748.
Crossref
Crossref
QIQIN JIANG, QIONGYU LI, HONGWEI CHEN, ALING SHEN, QIAOYAN CAI, JIUMAO LIN & JUN PENG. (2015) Scutellaria barbata D. Don inhibits growth and induces apoptosis by suppressing IL-6-inducible STAT3 pathway activation in human colorectal cancer cells. Experimental and Therapeutic Medicine 10:4, pages 1602-1608.
Crossref
Crossref
Zachary L. Chelsky, Peibin Yue, Tamara P. Kondratyuk, David Paladino, John M. Pezzuto, Mark Cushman & James Turkson. (2015)
A Resveratrol Analogue Promotes ERK
MAPK
–Dependent Stat3 Serine and Tyrosine Phosphorylation Alterations and Antitumor Effects In Vitro against Human Tumor Cells
. Molecular Pharmacology 88:3, pages 524-533.
Crossref
Crossref
Eun Ji Joo, Jaemoo Chun, Young Wan Ha, Hye Jin Ko, Mei-Ying Xu & Yeong Shik Kim. (2015) Novel roles of ginsenoside Rg3 in apoptosis through downregulation of epidermal growth factor receptor. Chemico-Biological Interactions 233, pages 25-34.
Crossref
Crossref
Girolamo Ranieri, Ilaria Marech, Marianna Pantaleo, Mariagrazia Piccinno, Maria Roncetti, Maddalena Mutinati, Annalisa Rizzo, Cosmo Damiano Gadaleta, Marcello Introna, Rosa Patruno & Raffaele Luigi Sciorsci. (2015) In vivo model for mastocytosis: A comparative review. Critical Reviews in Oncology/Hematology 93:3, pages 159-169.
Crossref
Crossref
Halina Antosz, Katarzyna Wojciechowska, Joanna Sajewicz, Dorota Choroszyńska, Barbara Marzec-Kotarska, Magdalena Osiak, Natalia Pająk, Waldemar Tomczak, Małgorzata Jargiełło-Baszak & Jacek Baszak. (2015) IL-6, IL-10, c-Jun and STAT3 expression in B-CLL. Blood Cells, Molecules, and Diseases 54:3, pages 258-265.
Crossref
Crossref
Eleonora Guadagnin, Jigna Narola, Carsten G. Bönnemann & Yi-Wen Chen. (2015)
Tyrosine 705 Phosphorylation of STAT3 Is Associated with Phenotype Severity in TGF
β
1 Transgenic Mice
. BioMed Research International 2015, pages 1-7.
Crossref
Crossref
XIAOJIAN LIU, QINGHUAN XIAO, XUEFENG BAI, ZHAOJIN YU, MINGLI SUN, HAISHAN ZHAO, XIAOYI MI, ENHUA WANG, WEIFAN YAO, FENG JIN, LIN ZHAO, JIE REN & MINJIE WEI. (2014) Activation of STAT3 is involved in malignancy mediated by CXCL12-CXCR4 signaling in human breast cancer. Oncology Reports 32:6, pages 2760-2768.
Crossref
Crossref
YONGSHENG BAI, GUANGHUI XU, MENGXUE XU, QI LI & XINYUE QIN. (2014) Inhibition of Src phosphorylation reduces damage to the blood-brain barrier following transient focal cerebral ischemia in rats. International Journal of Molecular Medicine 34:6, pages 1473-1482.
Crossref
Crossref
MINGHE LI, ZHIHONG LI, CHONGYANG LIANG, CHENGMIN HAN, WEI HUANG & FEI SUN. (2014) Upregulation of GRIM-19 suppresses the growth of oral squamous cell carcinoma in vitro and in vivo. Oncology Reports 32:5, pages 2183-2190.
Crossref
Crossref
V.E. Johnson, E.C. Vonderheid, A.D. Hess, C.M. Eischen & L.Y. McGirt. (2013) Genetic markers associated with progression in early mycosis fungoides. Journal of the European Academy of Dermatology and Venereology 28:11, pages 1431-1435.
Crossref
Crossref
Xing-Hua Liao, Nan Wang, Long-Yue Liu, Li Zheng, Wen-Jing Xing, Dong-Wei Zhao, Xue-Guang Sun, Peng Hu, Jian Dong & Tong-Cun Zhang. (2014) MRTF-A and STAT3 synergistically promote breast cancer cell migration. Cellular Signalling 26:11, pages 2370-2380.
Crossref
Crossref
Snehal Dabir, Amy Kluge, Adam Kresak, Michael Yang, Pingfu Fu, Bernd Groner, Gary Wildey & Afshin Dowlati. (2014) Low PIAS3 Expression in Malignant Mesothelioma Is Associated with Increased STAT3 Activation and Poor Patient Survival. Clinical Cancer Research 20:19, pages 5124-5132.
Crossref
Crossref
GUI-MIN WANG, ZHONG-XI REN, PEI-SONG WANG, CHANG SU, WEN-XIN ZHANG, ZENG-GUANG LIU, LING ZHANG, XUE-JIAN ZHAO & GUANG CHEN. (2014) Plasmid-based Stat3-specific siRNA and GRIM-19 inhibit the growth of thyroid cancer cells in vitro and in vivo. Oncology Reports 32:2, pages 573-580.
Crossref
Crossref
Qing ZHANG, Jing-Li LIU, Xiao-Man QI, Chun-Ting QI & Qiang YU. (2014) Inhibitory activities of Lignum Sappan extractives on growth and growth-related signaling of tumor cells. Chinese Journal of Natural Medicines 12:8, pages 607-612.
Crossref
Crossref
Jiawei Liu, Qing Zhang, Yushan Ye, Wuguo Li, Junxin Qiu, Jingli Liu, Ruoting Zhan, Weiwen Chen & Qiang Yu. (2014) Angoline: A selective IL-6/STAT3 signaling pathway inhibitor isolated from Zanthoxylum nitidum. Phytomedicine 21:8-9, pages 1088-1091.
Crossref
Crossref
LI ZHANG, YANXIN ZHENG, HONGZHU DENG, LEI LIANG & JUAN PENG. (2014) Aloperine induces G2/M phase cell cycle arrest and apoptosis in HCT116 human colon cancer cells. International Journal of Molecular Medicine 33:6, pages 1613-1620.
Crossref
Crossref
Nicholas Don-Doncow, Zilma Escobar, Martin Johansson, Sven Kjellström, Victor Garcia, Eduardo Munoz, Olov Sterner, Anders Bjartell & Rebecka Hellsten. (2014) Galiellalactone Is a Direct Inhibitor of the Transcription Factor STAT3 in Prostate Cancer Cells. Journal of Biological Chemistry 289:23, pages 15969-15978.
Crossref
Crossref
Dimiter B. Avtanski, Arumugam Nagalingam, Michael Y. Bonner, Jack L. Arbiser, Neeraj K. Saxena & Dipali Sharma. (2014) Honokiol inhibits epithelial-mesenchymal transition in breast cancer cells by targeting signal transducer and activator of transcription 3/Zeb1/E-cadherin axis. Molecular Oncology 8:3, pages 565-580.
Crossref
Crossref
Shegan Gao, Jonathan Brown, Huizhi Wang & Xiaoshan Feng. (2013) The Role of Glycogen Synthase Kinase 3-β in Immunity and Cell Cycle: Implications in Esophageal Cancer. Archivum Immunologiae et Therapiae Experimentalis 62:2, pages 131-144.
Crossref
Crossref
Claire L. Donohoe, Naoimh J. O’Farrell, Suzanne L. Doyle & John V. Reynolds. (2013) The role of obesity in gastrointestinal cancer: evidence and opinion. Therapeutic Advances in Gastroenterology 7:1, pages 38-50.
Crossref
Crossref
Revanna C. N, Basappa, Srinivasa V, Feng Li, Kodappully Sivaraman Siveen, Xiaoyun Dai, Shivananju Nanjunda Swamy, Bhadregowda D. G, Gautam Sethi, Mantelingu K, Andreas Bender & Rangappa KS. (2014) Synthesis and biological evaluation of tetrahydropyridinepyrazoles (‘PFPs’) as inhibitors of STAT3 phosphorylation. MedChemComm 5:1, pages 32.
Crossref
Crossref
Juliana Valencia-Serna, Breanne Landry, Xiaoyan Jiang & Hasan Uludag. 2014. Intracellular Delivery II. Intracellular Delivery II
435
473
.
Jennifer Hardee, Zhengqing Ouyang, Yuping Zhang, Anshul Kundaje, Philippe Lacroute & Michael Snyder. (2013) STAT3 Targets Suggest Mechanisms of Aggressive Tumorigenesis in Diffuse Large B-Cell Lymphoma. G3 Genes|Genomes|Genetics 3:12, pages 2173-2185.
Crossref
Crossref
Xi Chen, Jianhua Xuan, Chen Wang, Ayesha N. Shajahan, Rebecca B. Riggins & Robert Clarke. (2013) Reconstruction of Transcriptional Regulatory Networks by Stability-Based Network Component Analysis. IEEE/ACM Transactions on Computational Biology and Bioinformatics 10:6, pages 1347-1358.
Crossref
Crossref
S Jin, A P Mutvei, I V Chivukula, E R Andersson, D Ramsköld, R Sandberg, K L Lee, P Kronqvist, V Mamaeva, P Östling, J-P Mpindi, O Kallioniemi, I Screpanti, L Poellinger, C Sahlgren & U Lendahl. (2012) Non-canonical Notch signaling activates IL-6/JAK/STAT signaling in breast tumor cells and is controlled by p53 and IKKα/IKKβ. Oncogene 32:41, pages 4892-4902.
Crossref
Crossref
Christine A. King. (2013) Kaposi's Sarcoma-Associated Herpesvirus Kaposin B Induces Unique Monophosphorylation of STAT3 at Serine 727 and MK2-Mediated Inactivation of the STAT3 Transcriptional Repressor TRIM28. Journal of Virology 87:15, pages 8779-8791.
Crossref
Crossref
Gabriella Miklossy, Tyvette S. Hilliard & James Turkson. (2013) Therapeutic modulators of STAT signalling for human diseases. Nature Reviews Drug Discovery 12:8, pages 611-629.
Crossref
Crossref
Yubo Fan, Ren Kong, David J. Tweardy & Stephen T. Wong. (2013) WITHDRAWN: Intrinsic molecular characteristics of inhibiting STAT3 activation and dimerization through targeting the phosphotyrosine binding site within the SH2 domain—A molecular dynamics study. Journal of Structural Biology.
Crossref
Crossref
Khatri Latha, Ming Li, Vaibhav Chumbalkar, Anupama Gururaj, YeoHyeon Hwang, Sumana Dakeng, Raymond Sawaya, Kenneth Aldape, Webster K. Cavenee, Oliver Bogler & Frank B. Furnari. (2012) Nuclear EGFRvIII‐STAT5b complex contributes to glioblastoma cell survival by direct activation of the Bcl‐XL promoter. International Journal of Cancer 132:3, pages 509-520.
Crossref
Crossref
Robert Linke, Ralph Pries, Michael Könnecke, Karl Ludwig Bruchhage, Robert Böscke, Maximilian Gebhard & Barbara Wollenberg. (2013) Increased Activation and Differentiated Localization of Native and Phosphorylated STAT3 in Nasal Polyps. International Archives of Allergy and Immunology 162:4, pages 290-298.
Crossref
Crossref
Ji Hoon Jung, Tae-Rin Kwon, Soo-Jin Jeong, Eun-Ok Kim, Eun Jung Sohn, Miyong Yun & Sung-Hoon Kim. (2013) Apoptosis Induced by Tanshinone IIA and Cryptotanshinone Is Mediated by Distinct JAK/STAT3/5 and SHP1/2 Signaling in Chronic Myeloid Leukemia K562 Cells. Evidence-Based Complementary and Alternative Medicine 2013, pages 1-10.
Crossref
Crossref
Inken Wierstra. 2013.
191
419
.
Junjeong Choi, Do Hee Kim, Woo Hee Jung & Ja Seung Koo. (2012) Differential expression of immune-related markers in breast cancer by molecular phenotypes. Breast Cancer Research and Treatment 137:2, pages 417-429.
Crossref
Crossref
Karolina Swiatek-Machado & Bozena Kaminska. 2013. Glioma Signaling. Glioma Signaling
189
208
.
Shundong Cang, Nikhil Mukhi, Kemeng Wang & Delong Liu. (2012) Novel CD20 monoclonal antibodies for lymphoma therapy. Journal of Hematology & Oncology 5:1.
Crossref
Crossref
Raquel Tognon, Elainy PL Gasparotto, Renata P Neves, Natália S Nunes, Aline F Ferreira, Patrícia VB Palma, Simone Kashima, Dimas T Covas, Mary Santana, Elizabeth X Souto, Maria Aparecida Zanichelli, Belinda P Simões, Ana Maria de Souza & Fabíola A Castro. (2012) Deregulation of apoptosis-related genes is associated with PRV1 overexpression and JAK2 V617F allele burden in Essential Thrombocythemia and Myelofibrosis. Journal of Hematology & Oncology 5:1.
Crossref
Crossref
Caihong Chen, Haiyan Fang, Yumei Rao, Peng Wu, Yang He, Ding Ma & Qinglei Gao. (2012) Preliminary evaluation of safety of conditionally replication adenovirus M4. Journal of Huazhong University of Science and Technology [Medical Sciences] 32:6, pages 893-898.
Crossref
Crossref
Er-Wen Huang, Sheng-Jiang Xue, Zheng Zhang, Jia-Guo Zhou, Yong-Yuan Guan & Yong-Bo Tang. (2012) Vinpocetine inhibits breast cancer cells growth in vitro and in vivo. Apoptosis 17:10, pages 1120-1130.
Crossref
Crossref
Bikash Debnath, Shili Xu & Nouri Neamati. (2012) Small Molecule Inhibitors of Signal Transducer and Activator of Transcription 3 (Stat3) Protein. Journal of Medicinal Chemistry 55:15, pages 6645-6668.
Crossref
Crossref
Shr-Ping Teng, Wei-Li Hsu, Cheng-Yang Chiu, Min-Liang Wong & Shih-Chieh Chang. (2012) Overexpression of P-glycoprotein, STAT3, phospho-STAT3 and KIT in spontaneous canine cutaneous mast cell tumours before and after prednisolone treatment. The Veterinary Journal 193:2, pages 551-556.
Crossref
Crossref
Xiaoyi Huang, Fang Yuan, Meihua Liang, Hui-Wen Lo, Mari L. Shinohara, Cary Robertson & Pei Zhong. (2012) M-HIFU Inhibits Tumor Growth, Suppresses STAT3 Activity and Enhances Tumor Specific Immunity in a Transplant Tumor Model of Prostate Cancer. PLoS ONE 7:7, pages e41632.
Crossref
Crossref
MICHAEL SKYNNER, PHIL JEFFREY, MICHAEL BINKS & MICHAEL WOODROW. 2012. Anti-Inflammatory Drug Discovery. Anti-Inflammatory Drug Discovery
211
254
.
Xiaolei ZhangPeibin YueBrent D. G. Page, Tianshu LiWei ZhaoAndrew T. Namanja, David PaladinoJihe ZhaoYuan Chen, Patrick T. Gunning & James Turkson. (2012) Orally bioavailable small-molecule inhibitor of transcription factor Stat3 regresses human breast and lung cancer xenografts. Proceedings of the National Academy of Sciences 109:24, pages 9623-9628.
Crossref
Crossref
P Yue, X Zhang, D Paladino, B Sengupta, S Ahmad, R W Holloway, S B Ingersoll & J Turkson. (2011) Hyperactive EGF receptor, Jaks and Stat3 signaling promote enhanced colony-forming ability, motility and migration of cisplatin-resistant ovarian cancer cells. Oncogene 31:18, pages 2309-2322.
Crossref
Crossref
Roberto E Favoni, Antonio Daga, Paolo Malatesta & Tullio Florio. (2012) Preclinical studies identify novel targeted pharmacological strategies for treatment of human malignant pleural mesothelioma. British Journal of Pharmacology 166:2, pages 532-553.
Crossref
Crossref
XIAOFEI WANG, YAN ZHANG, XIWEN ZHANG, WENXIA TIAN, WENLI FENG & TINGMEI CHEN. (2012) The curcumin analogue hydrazinocurcumin exhibits potent suppressive activity on carcinogenicity of breast cancer cells via STAT3 inhibition. International Journal of Oncology 40:4, pages 1189-1195.
Crossref
Crossref
Zhenbing You, Dafu Xu, Jian Ji, Wei Guo, Weiguo Zhu & Jingdong He. (2012) JAK/STAT signal pathway activation promotes progression and survival of human oesophageal squamous cell carcinoma. Clinical and Translational Oncology 14:2, pages 143-149.
Crossref
Crossref
Meng Sun, Chengfei Liu, Nagalakshmi Nadiminty, Wei Lou, Yezi Zhu, Joy Yang, Christopher P. Evans, Qinghua Zhou & Allen C. Gao. (2011) Inhibition of Stat3 activation by sanguinarine suppresses prostate cancer cell growth and invasion. The Prostate 72:1, pages 82-89.
Crossref
Crossref
Wu ZL, Song YQ, Shi YF & J Zhu. (2011) High nuclear expression of STAT3 is associated with unfavorable prognosis in diffuse large B-cell lymphoma. Journal of Hematology & Oncology 4:1.
Crossref
Crossref
Jin-fang Zhang, Ming-liang He, Wei-ming Fu, Hua Wang, Lian-zhou Chen, Xiao Zhu, Ying Chen, Dan Xie, Paul Lai, Gong Chen, Gang Lu, Marie C.M. Lin & Hsiang-fu Kung. (2011) Primate-specific microRNA-637 inhibits tumorigenesis in hepatocellular carcinoma by disrupting signal transducer and activator of transcription 3 signaling. Hepatology 54:6, pages 2137-2148.
Crossref
Crossref
Judith Leibovici, Orit Itzhaki, Monica Huszar & Judith Sinai. (2011) Targeting the tumor microenvironment by immunotherapy: part 2. Immunotherapy 3:11, pages 1385-1408.
Crossref
Crossref
Rachel Haviland, Steven Eschrich, Gregory Bloom, Yihong Ma, Susan Minton, Richard Jove & W. Douglas Cress. (2011) Necdin, a Negative Growth Regulator, Is a Novel STAT3 Target Gene Down-Regulated in Human Cancer. PLoS ONE 6:10, pages e24923.
Crossref
Crossref
Jonathan M. Hernandez, Jeffrey M. Farma, Domenico Coppola, Ardeshir Hakam, William J. Fulp, Dung-Tsa Chen, Erin M. Siegel, Timothy J. Yeatman & David Shibata. (2011) Expression of the Antiapoptotic Protein Survivin in Colon Cancer. Clinical Colorectal Cancer 10:3, pages 188-193.
Crossref
Crossref
C J Guigon, D W Kim, M C Willingham & S-y Cheng. (2011) Mutation of thyroid hormone receptor-β in mice predisposes to the development of mammary tumors. Oncogene 30:30, pages 3381-3390.
Crossref
Crossref
Soumya Jaganathan, Peibin Yue, David C. Paladino, Jelena Bogdanovic, Qun Huo & James Turkson. (2011) A Functional Nuclear Epidermal Growth Factor Receptor, Src and Stat3 Heteromeric Complex in Pancreatic Cancer Cells. PLoS ONE 6:5, pages e19605.
Crossref
Crossref
Mian M.K. Shahzad, Lingegowda S. Mangala, Hee Dong Han, Chunhua Lu, Justin Bottsford-Miller, Masato Nishimura, Edna M. Mora, Jeong-Won Lee, Rebecca L. Stone, Chad V. Pecot, Duangmani Thanapprapasr, Ju-Won Roh, Puja Gaur, Maya P. Nair, Yun-Yong Park, Nirupama Sabnis, Michael T. Deavers, Ju-Seog Lee, Lee M. Ellis, Gabriel Lopez-Berestein, Walter J. McConathy, Laszlo Prokai, Andras G. Lacko & Anil K. Sood. (2011) Targeted Delivery of Small Interfering RNA Using Reconstituted High-Density Lipoprotein Nanoparticles. Neoplasia 13:4, pages 309-IN8.
Crossref
Crossref
Suzita M. Noor, Richard Bell & Alister C. Ward. (2011) Shooting the messenger: Targeting signal transduction pathways in leukemia and related disorders. Critical Reviews in Oncology/Hematology 78:1, pages 33-44.
Crossref
Crossref
Okkyung Rho, Dae Joon Kim, Karou Kiguchi & John DiGiovanni. (2011) Growth factor signaling pathways as targets for prevention of epithelial carcinogenesis. Molecular Carcinogenesis 50:4, pages 264-279.
Crossref
Crossref
Vijay M. Shahani, Peibin Yue, Steven Fletcher, Sumaiya Sharmeen, Mahadeo A. Sukhai, Diana P. Luu, Xiaolei Zhang, Hong Sun, Wei Zhao, Aaron D. Schimmer, James Turkson & Patrick T. Gunning. (2011) Design, synthesis, and in vitro characterization of novel hybrid peptidomimetic inhibitors of STAT3 protein. Bioorganic & Medicinal Chemistry 19:5, pages 1823-1838.
Crossref
Crossref
Vijay M. Shahani, Peibin Yue, Sina Haftchenary, Wei Zhao, Julie L. Lukkarila, Xiaolei Zhang, Daniel Ball, Christina Nona, Patrick T. Gunning & James Turkson. (2010) Identification of Purine-Scaffold Small-Molecule Inhibitors of Stat3 Activation by QSAR Studies. ACS Medicinal Chemistry Letters 2:1, pages 79-84.
Crossref
Crossref
B. Jiang, Z.Z. Zhu, F. Liu, L.J. Yang, W.Y. Zhang, H.H. Yuan, J.G. Wang, X.H. Hu & G. Huang. (2011) STAT3 gene polymorphisms and susceptibility to non-small cell lung cancer. Genetics and Molecular Research 10:3, pages 1856-1865.
Crossref
Crossref
Arash Haghikia, Britta Stapel, Melanie Hoch & Denise Hilfiker-Kleiner. (2010) STAT3 and cardiac remodeling. Heart Failure Reviews 16:1, pages 35-47.
Crossref
Crossref
Dagmar Hildebrand, Patrick Walker, Alexander Dalpke, Klaus Heeg & Katharina F. Kubatzky. (2010) Pasteurella multocida Toxin-induced Pim-1 expression disrupts suppressor of cytokine signalling (SOCS)-1 activity. Cellular Microbiology 12:12, pages 1732-1745.
Crossref
Crossref
Seán P. Barry, Paul A. Townsend, Richard A. Knight, Tiziano M. Scarabelli, David S. Latchman & Anastasis Stephanou. (2010) STAT3 modulates the DNA damage response pathway. International Journal of Experimental Pathology 91:6, pages 506-514.
Crossref
Crossref
Kenji Matsuno, Yoshiaki Masuda, Yutaka Uehara, Hiroshi Sato, Ayumu Muroya, Osamu Takahashi, Takane Yokotagawa, Toshio Furuya, Tadashi Okawara, Masami Otsuka, Naohisa Ogo, Tadashi Ashizawa, Chie Oshita, Sachiko Tai, Hidee Ishii, Yasuto Akiyama & Akira Asai. (2010) Identification of a New Series of STAT3 Inhibitors by Virtual Screening. ACS Medicinal Chemistry Letters 1:8, pages 371-375.
Crossref
Crossref
Wei Zhao, Soumya Jaganathan & James Turkson. (2010) A Cell-permeable Stat3 SH2 Domain Mimetic Inhibits Stat3 Activation and Induces Antitumor Cell Effects in Vitro. Journal of Biological Chemistry 285:46, pages 35855-35865.
Crossref
Crossref
Chunlei Zhang, Baoqiang Li, Xiang Zhang, Parul Hazarika, Bharat B. Aggarwal & Madeleine Duvic. (2010) Curcumin Selectively Induces Apoptosis in Cutaneous T-Cell Lymphoma Cell Lines and Patients’ PBMCs: Potential Role for STAT-3 and NF-κB Signaling. Journal of Investigative Dermatology 130:8, pages 2110-2119.
Crossref
Crossref
Soumya Jaganathan, Peibin Yue & James Turkson. (2010) Enhanced Sensitivity of Pancreatic Cancer Cells to Concurrent Inhibition of Aberrant Signal Transducer and Activator of Transcription 3 and Epidermal Growth Factor Receptor or Src. Journal of Pharmacology and Experimental Therapeutics 333:2, pages 373-381.
Crossref
Crossref
Xiaolei Zhang, Peibin Yue, Steven Fletcher, Wei Zhao, Patrick T. Gunning & James Turkson. (2010) A novel small-molecule disrupts Stat3 SH2 domain–phosphotyrosine interactions and Stat3-dependent tumor processes. Biochemical Pharmacology 79:10, pages 1398-1409.
Crossref
Crossref
Sutapa Banerjee, Jonathan N. Byrd, Scott M. Gianino, Scott E. Harpstrite, Fausto J. Rodriguez, Robert G. Tuskan, Karlyne M. Reilly, David R. Piwnica-Worms & David H. Gutmann. (2010)
The Neurofibromatosis Type 1 Tumor Suppressor Controls Cell Growth by Regulating Signal Transducer and Activator of Transcription-3 Activity
In vitro
and
In vivo
. Cancer Research 70:4, pages 1356-1366.
Crossref
Crossref
Navin Verma, Anthony Davies, Aideen Long, Dermot Kelleher & Yuri Volkov. (2010) STAT3 knockdown by siRNA induces apoptosis in human cutaneous T-cell lymphoma line Hut78 via downregulation of Bcl-xL. Cellular and Molecular Biology Letters 15:2.
Crossref
Crossref
R. C. Sobti, Neha Singh, Showket Hussain, Vanita Suri, A. C. Bharti & B. C. Das. (2009) Overexpression of STAT3 in HPV-mediated cervical cancer in a North Indian population. Molecular and Cellular Biochemistry 330:1-2, pages 193-199.
Crossref
Crossref
Rathindranath Baral, Anamika Bose, Chinmoyee Ray, Sonali Paul, Smarajit Pal, Enamul Haque, Bhagawan Mishra, Debolina Pal, Jatin Kumar Nagpal, Chinmay Kumar Panda & Bibhu Ranjan Das. (2009) Association of early phase of colorectal carcinogenesis with STAT3 activation and its relevance in apoptosis regulation. Experimental and Molecular Pathology 87:1, pages 36-41.
Crossref
Crossref
Yi-Hua Qian, Qingli Xiao, Hong Chen & Jan Xu. (2009) Dexamethasone inhibits camptothecin-induced apoptosis in C6-glioma via activation of Stat5/Bcl-xL pathway. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1793:5, pages 764-771.
Crossref
Crossref
Yutaka Uehara, Masato Mochizuki, Kenji Matsuno, Takeharu Haino & Akira Asai. (2009) Novel high-throughput screening system for identifying STAT3–SH2 antagonists. Biochemical and Biophysical Research Communications 380:3, pages 627-631.
Crossref
Crossref
Gordana Konjevic. (2009) STAT proteins in cancerogenesis and therapy of malignancies. Srpski arhiv za celokupno lekarstvo 137:1-2, pages 98-105.
Crossref
Crossref
Christian Perotti, Ruixuan Liu, Christine T Parusel, Nadine Böcher, Jörg Schultz, Peer Bork, Edith Pfitzner, Bernd Groner & Carrie S Shemanko. (2008) Heat shock protein-90-alpha, a prolactin-STAT5 target gene identified in breast cancer cells, is involved in apoptosis regulation. Breast Cancer Research 10:6.
Crossref
Crossref
Patrick T. Gunning, Matthew P. Glenn, Khandaker A. Z. Siddiquee, William P. Katt, Eric Masson, Saïd M. Sebti, James Turkson & Andrew D. Hamilton. (2008) Targeting Protein-Protein Interactions: Suppression of Stat3 Dimerization with Rationally Designed Small-Molecule, Nonpeptidic SH2 Domain Binders. ChemBioChem 9:17, pages 2800-2803.
Crossref
Crossref
Chunlei Zhang, Baoqiang Li, Amos S. Gaikwad, Valsala Haridas, Zhixiang Xu, Jordan U. Gutterman & Madeleine Duvic. (2008) Avicin D Selectively Induces Apoptosis and Downregulates p-STAT-3, bcl-2, and Survivin in Cutaneous T-Cell Lymphoma Cells. Journal of Investigative Dermatology 128:11, pages 2728-2735.
Crossref
Crossref
Steven Fletcher, James Turkson & Patrick T. Gunning. (2008) Molecular Approaches towards the Inhibition of the Signal Transducer and Activator of Transcription 3 (Stat3) Protein. ChemMedChem 3:8, pages 1159-1168.
Crossref
Crossref
Amit A. Lugade, Elizabeth W. Sorensen, Scott A. Gerber, James P. Moran, John G. Frelinger & Edith M. Lord. (2008) Radiation-Induced IFN-γ Production within the Tumor Microenvironment Influences Antitumor Immunity. The Journal of Immunology 180:5, pages 3132-3139.
Crossref
Crossref
Somshuvra Mukhopadhyay, Mehul Shah, Fang Xu, Kirit Patel, Rubin M. Tuder & Pravin B. Sehgal. (2008) Cytoplasmic provenance of STAT3 and PY-STAT3 in the endolysosomal compartments in pulmonary arterial endothelial and smooth muscle cells: implications in pulmonary arterial hypertension. American Journal of Physiology-Lung Cellular and Molecular Physiology 294:3, pages L449-L468.
Crossref
Crossref
P Fischer & D Hilfiker‐Kleiner. (2009) Role of gp130‐mediated signalling pathways in the heart and its impact on potential therapeutic aspects. British Journal of Pharmacology 153:S1.
Crossref
Crossref
Zhong Chen & Zhong Chao Han. (2007) STAT3: A critical transcription activator in angiogenesis. Medicinal Research Reviews 28:2, pages 185-200.
Crossref
Crossref
Rebecka Hellsten, Martin Johansson, Anna Dahlman, Nishtman Dizeyi, Olov Sterner & Anders Bjartell. (2007) Galiellalactone is a novel therapeutic candidate against hormone‐refractory prostate cancer expressing activated Stat3. The Prostate 68:3, pages 269-280.
Crossref
Crossref
Khandaker Al Zaid Siddiquee & James Turkson. (2008) STAT3 as a target for inducing apoptosis in solid and hematological tumors. Cell Research 18:2, pages 254-267.
Crossref
Crossref
Ling Zhang, Lifang Gao, Yang Li, Guimiao Lin, Yueting Shao, Kun Ji, Hao Yu, Jiadi Hu, Dhananjaya V. Kalvakolanu, Dennis J. Kopecko, Xuejian Zhao & De-Qi Xu. (2008) Effects of Plasmid-Based Stat3-Specific Short Hairpin RNA and GRIM-19 on PC-3M Tumor Cell Growth. Clinical Cancer Research 14:2, pages 559-568.
Crossref
Crossref
Seungchan Yang, Kyungho Park, James Turkson & Carlos L. Arteaga. (2008) Ligand-independent phosphorylation of Y869 (Y845) links mutant EGFR signaling to stat-mediated gene expression. Experimental Cell Research 314:2, pages 413-419.
Crossref
Crossref
Inken Wierstra & Jürgen Alves. 2008.
113
333
.
Khandaker A. Z. Siddiquee, Patrick T. Gunning, Matthew Glenn, William P. Katt, Shumin Zhang, Christopher Schroeck, Said M. Sebti, Richard Jove, Andrew D. Hamilton & James Turkson. (2007) An Oxazole-Based Small-Molecule Stat3 Inhibitor Modulates Stat3 Stability and Processing and Induces Antitumor Cell Effects. ACS Chemical Biology 2:12, pages 787-798.
Crossref
Crossref
Ying Huang, Jihui Qiu, Shuo Dong, Michele S. Redell, Valeria Poli, Michael A. Mancini & David J. Tweardy. (2007) Stat3 Isoforms, α and β, Demonstrate Distinct Intracellular Dynamics with Prolonged Nuclear Retention of Stat3β Mapping to Its Unique C-terminal End. Journal of Biological Chemistry 282:48, pages 34958-34967.
Crossref
Crossref
Arun Kumar, Syril Kumar Dorairaj, Venkatesh C. Prabhakaran, D. Ravi Prakash & Sanjukta Chakraborty. (2007) Identification of genes associated with tumorigenesis of meibomian cell carcinoma by microarray analysis. Genomics 90:5, pages 559-566.
Crossref
Crossref
Rosanede Oliveira Duarte AchcarPhilip T. CagleJaishree Jagirdar. (2007) Expression of Activated and Latent Signal Transducer and Activator of Transcription 3 in 303 Non–Small Cell Lung Carcinomas and 44 Malignant Mesotheliomas: Possible Role for Chemotherapeutic Intervention. Archives of Pathology & Laboratory Medicine 131:9, pages 1350-1360.
Crossref
Crossref
Hidefumi Sasaki, Katsuhiro Okuda, Katsuhiko Endo, Osamu Kawano, Haruhiro Yukiue, Tomoki Yokoyama, Motoki Yano & Yoshitaka Fujii. (2007) CCND1 Messenger RNA Expression Is Correlated with EGFR Mutation Status in Lung Cancer. Clinical Lung Cancer 8:8, pages 493-496.
Crossref
Crossref
Marjan Berishaj, Sizhi Paul Gao, Simi Ahmed, Kenneth Leslie, Hikmat Al-Ahmadie, William L Gerald, William Bornmann & Jacqueline F Bromberg. (2007) Stat3 is tyrosine-phosphorylated through the interleukin-6/glycoprotein 130/Janus kinase pathway in breast cancer. Breast Cancer Research 9:3.
Crossref
Crossref
Khandaker SiddiqueeShumin ZhangWayne C. GuidaMichelle A. Blaskovich, Benjamin Greedy, Harshani R. Lawrence, M. L. Richard Yip, Richard Jove, Mark M. McLaughlin, Nicholas J. LawrenceSaid M. Sebti & James Turkson. (2007) Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity. Proceedings of the National Academy of Sciences 104:18, pages 7391-7396.
Crossref
Crossref
Geoffrey Bartholomeusz, Moshe Talpaz, William Bornmann, Ling-Yuan Kong & Nicholas J. Donato. (2007) Degrasyn Activates Proteasomal-Dependent Degradation of c-Myc. Cancer Research 67:8, pages 3912-3918.
Crossref
Crossref
Henry M. SmilowitzJakob Weissenberger, Joachim WeisJudith D. Brown, Rachel J. O'Neill & Jean A. Laissue. (2007) Orthotopic transplantation of v-src–expressing glioma cell lines into immunocompetent mice: establishment of a new transplantable in vivo model for malignant glioma. Journal of Neurosurgery 106:4, pages 652-659.
Crossref
Crossref
Displaying 200 of 228 citing articles. Use the download link below to view the full list of citing articles.
Download full citations list